Skip to main content
. 2013 Apr 12;15(7):904–920. doi: 10.1093/neuonc/not035

Fig. 3.

Fig. 3.

Fig. 3.

Fig. 3.

MYXV replicated in SCID mice bearing intracranial human BTICs and rapamycin promotes virus replication in some lines in vivo. (A and B) Representative viral bioluminescence images and quantification of the virus (photons/s) in BT025 line after treatment with MYXV + rapamycin at the different times. (C and D) Representative viral bioluminescence images and quantification of the virus (photons/s) in BT048 line after treatment with MYXV + rapamycin at the different times. (E and F) Viral titers (FFUs/g tumor tissue) in BT025- and BT048-bearing mice treated with MYXV + rapamycin (*P < .05, **P < .01 compared by Student's t-test with MYXV alone).